Skip to main content
Henry Kranzler, MD, Psychiatry, Philadelphia, PA

HenryRKranzlerMD

Psychiatry • Philadelphia, PA

Addiction, Psychopharmacology, Clinical Pharmacology

Professor, Psychiatry, Perelman School of Medicine

Join to view full profile

Dr. Kranzler is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Kranzler's full profile

Already have an account?

  • Office

    3535 Market St, Suite 500
    Philadelphia, PA 19104
    Phone+1 215-746-1943
    Fax+1 860-679-6736

Summary

  • Dr. Henry Kranzler is a psychiatrist in Philadelphia, PA and is affiliated with multiple hospitals in the area, including Hospital of the University of Pennsylvania, Philadelphia Veterans Affairs Medical Center, and Penn Presbyterian Medical Center. He received his medical degree from Rutgers Robert Wood Johnson Medical School and has been in practice 35 years. He specializes in addiction and psychopharmacology and is experienced in genetics of addiction, pharmacotherapy of alcohol dependence, pharmacogenetics of heavy drinking.

Education & Training

  • University of Connecticut
    University of ConnecticutResidency, Psychiatry, 1982 - 1986
  • Rutgers Robert Wood Johnson Medical School
    Rutgers Robert Wood Johnson Medical SchoolClass of 1982

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2010 - 2024
  • CT State Medical License
    CT State Medical License 1984 - 2011
  • American Board of Psychiatry and Neurology Psychiatry

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Discovery of the First Genome-Wide Significant Risk Loci for Attention deficit/hyperactivity Disorder  
    Henry R Kranzler, Hakon Hakonarson, Michael Gandal, Elise B Robinson, Nature
  • Genome‐Wide Association Meta‐Analysis of Age at First Cannabis Use  
    Henry R Kranzler, Joel Gelernter, Tamara L Wall, Addiction
  • AUDIT‐C and ICD Codes as Phenotypes for Harmful Alcohol Use: Association with ADH1B Polymorphisms in Two U.S. Populations  
    David A Fiellin, William C Becker, Joel Gelernter, Henry R Kranzler, Ning Sun, John Concato, Addiction
  • Join now to see all

Authored Content

  • F131. Genome-Wide Association Study Identifies Glutamate Ionotropic Receptor GRIA4 as a Risk Gene for Comorbid Nicotine Dependence and Major DepressionApril 2018
  • F131. Genome-Wide Association Study Identifies Glutamate Ionotropic Receptor GRIA4 as a Risk Gene for Comorbid Nicotine Dependence and Major DepressionApril 2018
  • Genome-Wide Association Study Identifies a Regulatory Variant of RGMA Associated with Opioid Dependence in European AmericansJanuary 2018
  • Genome-Wide Association Study Identifies a Regulatory Variant of RGMA Associated with Opioid Dependence in European AmericansJanuary 2018
  • Join now to see all

Press Mentions

  • Binge Drinking May Be Curbed with a Pill
    Binge Drinking May Be Curbed with a PillFebruary 14th, 2023
  • Generic Heart Pill Shows Early Promise for Alcohol Use Disorder
    Generic Heart Pill Shows Early Promise for Alcohol Use DisorderSeptember 23rd, 2022
  • Psilocybin-Assisted Therapy Could Help Reduce Heavy Drinking, Study Finds
    Psilocybin-Assisted Therapy Could Help Reduce Heavy Drinking, Study FindsAugust 29th, 2022
  • Join now to see all

Grant Support

  • Component V: Topiramante Treatment Of Problem DrinkersNational Institute On Alcohol Abuse And Alcoholism2008–2012
  • Deep Sequencing Studies For Cannabis And Stimulant DependenceNational Institute On Drug Abuse2010–2011
  • Genetics Of Cocaine DependenceNational Institute On Drug Abuse2006–2010
  • Novel Approaches To Alcoholism Pharmacotherapy And RiskNational Institute On Alcohol Abuse And Alcoholism2002–2010
  • Clinical Trial: Sertraline PharmacotherapyNational Center For Research Resources2008
  • Targeted Naltrexone For Problem DrinkersNational Center For Research Resources2004–2008
  • Genetics Of Opioid DependenceNational Center For Research Resources2004–2008
  • Genetics Of Cocaine DependenceNational Center For Research Resources2004–2008
  • Genetics Of Alcohol DependenceNational Center For Research Resources2004–2008
  • Effects Of Aripiprazole On Subjective And Physiological Responses To AlcoholNational Center For Research Resources2007
  • Sertraline PharmacotherapyNational Center For Research Resources2004–2007
  • Targeted Naltrexone For Early Problem DrinkersNational Institute On Alcohol Abuse And Alcoholism2003–2007
  • Sertraline Pharmacotherapy For Alcoholism SubtypesNational Institute On Alcohol Abuse And Alcoholism2003–2007
  • Planning For A CTSA Application At The University Of ConnecticutNational Center For Research Resources2006
  • Memantine For Alcohol Dependence: An Open-Label Pilot StudyNational Center For Research Resources2005–2006
  • Naltrexone InjectionsNational Center For Research Resources2004
  • Molecular Genetics And Drug DependenceNational Center For Research Resources2004
  • Genetic Vulnerability Of Cocaine Associated PsychosisNational Center For Research Resources2004
  • FinasterideNational Center For Research Resources2004
  • Scientific Review And Evaluation AwardNational Institute On Alcohol Abuse And Alcoholism2002–2003
  • Genetic Studies Of Naltrexone Response In AlcoholicsNational Center For Research Resources1999–2002
  • Oral Versus Depot Naltrexone For Relapse PreventionNational Institute On Alcohol Abuse And Alcoholism1998–2002
  • Long Acting Depot Formulation Of Naltrexone For Alcohol DependenceNational Center For Research Resources1998–2002
  • Effect Of Tryptophan Depletion On Mood And Craving In Patients With DepressionNational Center For Research Resources1998–2002
  • Nefazodone, Naltrexone And Placebo With Relapse Prevention Of AlcoholismNational Center For Research Resources1997–2002
  • Association Of DRD3 Alleles And Cocaine UseNational Center For Research Resources1997–2002
  • Opioid Neurotransmission And Risk Of AlcoholismNational Center For Research Resources1996–2002
  • New Approaches To The Pharmacotherapy Of AlcoholismNational Institute On Alcohol Abuse And Alcoholism1997–2001
  • Targeted Naltrexone For Early Problem DrinkersNational Institute On Alcohol Abuse And Alcoholism1996–2000
  • Long-Acting Depot Formulation Of Naltrexone For Alcohol DependenceNational Center For Research Resources1997
  • Randomized Clinical Trial Of GepironeNational Institute On Alcohol Abuse And Alcoholism1996–1997
  • Molecular Genetic Studies Of Drug Abuse--Use Of HRRNational Institute On Drug Abuse1995–1996
  • Matching Alcoholic Subtypes To Specific MedicationsNational Institute On Alcohol Abuse And Alcoholism1992–1996

External Links

Dr. Henry Kranzler, Dr. Henry Kranzler, MD, Dr. H Kranzler, Dr. Henry R Kranzler